The recent XRP price surge is largely attributed to increased institutional investment. Institutional investors have poured cash into Ripple (XRP) … Continue reading ...
Shares of Synopsys declined after posting an outlook for the current fiscal year and the first quarter that missed analysts' estimates. The stock retreated 6% to $550.53 in after-hours trading ...
News of an analyst's price-target hike plus a new round of capital-raising were the sparks that ignited Janux Therapeutics ( JANX 11.65%) stock on Wednesday. The clinical-stage biotech's share price ...